FY2020 Earnings Estimate for Cineplex Inc Issued By National Bank Financial (TSE:CGX)

Share on StockTwits

Cineplex Inc (TSE:CGX) – Analysts at National Bank Financial lowered their FY2020 earnings estimates for Cineplex in a research note issued on Wednesday, February 12th. National Bank Financial analyst A. Shine now forecasts that the company will post earnings of $1.08 per share for the year, down from their previous forecast of $1.16. National Bank Financial has a “Tender” rating and a $34.00 price objective on the stock.

Cineplex (TSE:CGX) last issued its quarterly earnings data on Thursday, November 14th. The company reported C$0.24 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of C$0.14 by C$0.10. The business had revenue of C$418.45 million for the quarter, compared to analyst estimates of C$413.10 million.

Other equities research analysts also recently issued reports about the company. CIBC downgraded Cineplex from an “outperform” rating to a “neutral” rating and upped their target price for the stock from C$29.00 to C$34.00 in a research report on Tuesday, December 17th. TD Securities downgraded Cineplex from a “hold” rating to a “tender” rating and set a C$34.00 target price for the company. in a research report on Tuesday, February 4th. Canaccord Genuity downgraded Cineplex from a “buy” rating to a “hold” rating and upped their target price for the stock from C$31.00 to C$34.00 in a research report on Tuesday. Finally, Royal Bank of Canada downgraded Cineplex from an “outperform” rating to a “sector perform” rating and upped their target price for the stock from C$32.00 to C$34.00 in a research report on Tuesday, December 17th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Cineplex currently has a consensus rating of “Hold” and a consensus price target of C$32.71.

CGX opened at C$33.81 on Friday. The company has a market capitalization of $2.14 billion and a price-to-earnings ratio of 40.78. The company has a debt-to-equity ratio of 335.67, a current ratio of 0.43 and a quick ratio of 0.30. Cineplex has a 1-year low of C$22.25 and a 1-year high of C$34.39. The business has a 50 day moving average price of C$33.90 and a two-hundred day moving average price of C$27.30.

The company also recently announced a monthly dividend, which will be paid on Friday, February 28th. Shareholders of record on Friday, January 31st will be given a $0.15 dividend. The ex-dividend date is Thursday, January 30th. This represents a $1.80 dividend on an annualized basis and a yield of 5.32%. Cineplex’s dividend payout ratio (DPR) is 212.91%.

Cineplex Company Profile

Cineplex Inc, through its subsidiaries, operates as an entertainment and media company in Canada and internationally. It operates through three segments: Film Entertainment and Content, Media, and Amusement and Leisure. The Film Entertainment and Content segment operates film theatres; and provides food and in-theatre amusement services, as well as rents theatre and digital commerce.

Featured Article: What is a Tariff?

Receive News & Ratings for Cineplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cineplex and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Cincinnati Bell Inc.  Receives $10.50 Average Target Price from Analysts
Cincinnati Bell Inc. Receives $10.50 Average Target Price from Analysts
Zacks: Analysts Expect Barings BDC Inc  to Announce $0.16 Earnings Per Share
Zacks: Analysts Expect Barings BDC Inc to Announce $0.16 Earnings Per Share
$0.19 EPS Expected for Genie Energy Ltd  This Quarter
$0.19 EPS Expected for Genie Energy Ltd This Quarter
Phathom Pharmaceuticals  Receives Average Recommendation of “Strong Buy” from Brokerages
Phathom Pharmaceuticals Receives Average Recommendation of “Strong Buy” from Brokerages
Recent Research Analysts’ Ratings Updates for Gerresheimer
Recent Research Analysts’ Ratings Updates for Gerresheimer
Brokerages Expect Allogene Therapeutics Inc  to Post -$0.69 EPS
Brokerages Expect Allogene Therapeutics Inc to Post -$0.69 EPS


 
© 2006-2020 Zolmax.